Cytogenetic and antineoplastic effects of modified steroidal alkylators

Genetic Testing and Molecular Biomarkers

Volumn 14, Issue 1, 2010, Pages 93-97

  Karapidaki, Irini ^a,b   Papageorgiou, Athanasios ^c   Geromichalos, George ^c   Fousteris, Manolis ^d   Papaconstadinou, Ioanna ^d   Pairas, George ^d   Koutsourea, Anna ^d   Mourelatos, Denis ^a   Nikolaropoulos, Sotiris ^d   Lialiaris, Theodoros ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c Theagenion Anticancer Institute   (Greece)

^d UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA ANDROSTAN 7 17 DION PENTO N,N BIS(2 CHLOROETHYL)AMINOPHENYL ACETATE; 3BETA HYDROXY 17A AZA DEXTRO HOMO ANDROSTAN 7 ONE PENTO N,N BIS(2 CHLOROETHYL)AMINOPHENYL BUTURATE; 3BETA HYDROXY 17BETA ACETAMIDO ANDROSTAN 7 ONE PENTO N,N BIS(2 CHLOROETHYL)AMINOPHENYL BUTURATE; 3BETA HYDROXY ANDROSTAN 7 17 DION PENTO N,N BIS(2 CHLOROETHYL)AMINOPHENYL ACETATE; ANTILEUKEMIC AGENT; CHLORMETHINE DERIVATIVE; CYTOSTATIC AGENT; STEROID; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSTASIS; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG POTENCY; ESTERIFICATION; GENOTOXICITY; HUMAN; HUMAN CELL; LD 50; LETHAL DOSE; LEUKEMIA L 1210; LIFESPAN; LYMPHATIC LEUKEMIA; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NORMAL HUMAN; SISTER CHROMATID EXCHANGE; STRUCTURE ACTIVITY RELATION;

ANDROSTANES; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CELL PROLIFERATION; CELLS, CULTURED; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LEUKEMIA L1210; LYMPHOCYTES; MICE; MOLECULAR STRUCTURE; SISTER CHROMATID EXCHANGE;

MUS;

EID: 76949092648     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2009.0059     Document Type: Article

References (13)

1. Brendel M, Ruhland A (1984) Relationships between functionality and genetic toxicology of selected DNA-damaging agents. Mutat Res 133:51-85.
2. Catsoulacos P (1984) Further studies on the anti-neoplastic activity of 3b-hydroxy-13alpha-amino-13,17 seco-5alpha-androstan-17-oic-13,17-lactam [p-[bis(2-chloroethyl)amino]-phenyl] acetate (NSC290205). Cancer Lett 22:199-202.
3. Deen DF, Kendal LE, Marton LJ, et al. (1986) Prediction of human tumor cell chemosensitivity using the sister chromatid exchange assay. Cancer Res 46 (4 Pt 1):1599-1602.
4. Fousteris MA, Koutsourea AI, Arsenou ES, et al. (2002) Antileukemic and cytogenetic effects of modified and nonmodified esteric steroidal derivatives of 4-methyl-3-bis(2-chloroethyl) amino benzoic acid (4-Me-CABA). Anticancer Res 22:2293-2299.
5. Fousteris MA, Papageorgiou A, Arsenou ES, et al. (2007) Antileukemic and cytogenetic activity by triple administration of three modified steroidal derivatives of nitrogen mustards. Chemotherapy 53:118-126.
6. Goto K, Maeda S, Kano Y, et al. (1978) Factors involved in differential Giemsa-staining of sister chromatids. Chromosoma 66:351-359.
7. Karapidaki I, Bakopoulou A, Papageorgiou A, et al. (2009) Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized anti-tumor steroidal esters. Mutat Res 675:51-59.
8. Karayianni V, Mioglou E, Iakovidou Z, et al. (2003) A new approach for evaluating in vivo anti-leukemic activity using the SCE assay. An application on three newly synthesised antitumour steroidal esters. Mutat Res 535:79-86.
9. Koutsourea AI, Fousteris MA, Arsenou ES, et al. (2008a) Rational design, synthesis and in vivo evaluation of the antileukemic activity of six new alkylating steroidal esters. Bioorg Med Chem 16:5207-5215.
10. Koutsourea AI, Fousteris MA, Arsenou ES, et al. (2008b) Synthesis, in vivo antileukemic evaluation and comparative study of novel 5alpha-7-keto steroidal esters of chlorambucil and its active metabolite. In Vivo 22:345-352.
11. Mourelatos D (1996) Chromosomes study as predictor of chemoresponse of tumours, Cancer J 9:136-141.
12. Papageorgiou A, Koutsourea AI, Arsenou ES, et al. (2005) Structure-anti-leukemic activity relationship study of B-and D-ring modified and non-modified steroidal esters of chlorambuciles active metabolite. Anticancer Drugs 16:1075-1082.
13. Wasan H, Waxman J (1996) Cell proliferation in cancer regulatory mechanisms of neoplastic cell growth. In: Pusztai LL, Lewis CE, Yap E (eds) Oxford University Press, Oxford, pp 260-281.